RIGHT TO HEALTHCARE: A DOCTRINAL STUDY OF COMPULSORY LICENSING OF MEDICINES IN INDIA
DOI:
https://doi.org/10.29121/shodhkosh.v4.i1.2023.5242Keywords:
Compulsory Licensing, Government Use, Access To Medicines, Research and DevelopmentAbstract [English]
In today’s world, each one relies on one or more pills to survive and extend their life amid new diseases. Though the advancement of science and technology certainly resulted in numerous changes in society; it has not come up with a panacea to cure the most challenging survival issue which is to combat poverty and disparity. Pharmaceutical companies are like a demi-god and they decide who should live and who not. Patent for R&D to encourage and incentivize creators has, on the other hand, posed a threat to the public in accessing and affording the patented products, especially in the case of medicine and health. The disparity among world nations and the application of one general rule to overcome the situation concerning access the medicine is not a proper solution. However compulsory licensing issued to balance the disadvantages caused by issuing patents has to be analyzed concerning its working. Hence this article would throw light on the use of the compulsory license by the government with special reference to accessing medicines. To analyze the same this paper would extensively discuss the Conceptual viewpoint of compulsory licensing, the phase of the patent in public health, use of the compulsory license by the government with special reference to accessing medicines.
References
Jason Mirabito, Compulsory Patent Licensing for the United States: A Current Proposal, 57 J. PAT. OFF. Soc'y 404 (1975). 7 Ganguli, P. (1999, December). Towards TRIPs compliance in India: The Patents Amendment Act 1999 and implications. World Patent Information, 21(4), 279–287.
Camilla Alexandra Hrdy & Daniel Harris Brean, The Patent Law Origins of Science Fiction.
D. Yang, Compulsory Licensing: For Better or For Worse, the Done Deal Lies in the Balance, 17 Journal of Intellectual Property Rights 76 (2012).
Ganguli, P. (1999, December). Towards TRIPs compliance in India: The Patents Amendment Act 1999 and implications. World Patent Information, 21(4), 279–287. DOI: https://doi.org/10.1016/S0172-2190(00)00012-0
Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries, https://www.gilead.com/news-and-press/press-room/press-releases/2014/9/gilead-announces-genericlicensing-agreements-to-increase-access-to-hepatitis-c-treatments-in-developing-countries
History of Indian Patent System, Intellectual Property India, https://ipindia.gov.in/history-of-indian-patentsystem.
Natco Pharma Ltd. v. Bayer Corporation & The Controller of Patents, Madras & Others, (2013) 10 SCC 463.
Rupali Mukherjee, Bristol-Myers misleading HC in patent case, TOI , Sep. 14, 2013, https://timesofindia.indiatimes.com/business/india-business/bristol-myers-misleading-hc-in-patentcase/articleshow/22568901.cms
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Prof. (Dr.) K.S. Gopalakrishnan

This work is licensed under a Creative Commons Attribution 4.0 International License.
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.